COVID-19 and vitamin D supplementation: Is there any evidence based to reduce the risk?
Several studies and meta-analysis suggest that vitamin D deficiency constitutes a risk factor for acute respiratory infections while supplementation may reduce this risk. Given the current context of the COVID-19 pandemic, the role of vitamin D supplementation in the prevention and improvement of the prognosis of affected patients has been suggested by some studies and refuted by others. Through this article, we report the mechanisms of action and properties of vitamin D, and we discuss the different hypotheses of the involvement of vitamin D in respiratory infections, especially Covid-19 in the light of the most recent published data.
Keywords
How to Cite
Similar Articles
- Traditional Tunisian Pasta "Nwasser" Enriched with Wheat Bran: Impact on Physicochemical Quality, Nutritional Profile, and Acute Post-Prandial Glycemic Response in Healthy Individuals
- Nutrition situation of Burkina Faso: a narrative review
- Comparative Nutritional Characterization of a Novel Formulated Composite Milk Alternative and a Conventional Infant Formula
- Bioactive molecules of grape
- Investigating bacterial gastroenteritis prevalence in the population of Tizi-Ouzou city under the context of social distancing and barrier measures
- Pica in sickle cell disease: nutritional management and implications
- Enhancing Freshwater Fish Consumption in Algeria: A Study on the Nutritional and Sensory Attributes of Common Carp Sticks
- The Association Between Perceived Stress, Lifestyle and Dietary Behaviors, and Hypertension Among University Personnel
- Nutritional Status, Muscle Mass, and Body Fat Percentage in Patients with Breast Cancer Undergoing Adjuvant Chemotherapy
- Evaluation of Nutritional Status Among COVID-19 Patients Admitted to the Intensive Care Unit in Jeddah, Saudi Arabia: A Cross-Sectional Observational Study
You may also start an advanced similarity search for this article.
NAJFNR is licensed under